Epigenomics AG: Noel Doheny Appointed as New CEO of US-Subsidiary Epigenomics Inc.

26-Apr-2011 - USA

Epigenomics AG announced the appointment of Noel Doheny as the new Chief Executive Officer (CEO) of its subsidiary Epigenomics Inc. in Seattle, WA, USA, reporting to Geert Nygaard, CEO of Epigenomics AG. Mr. Doheny will start in his new position in early May 2011.

Mr. Doheny has 30+ years of experience in the field of diagnostics, with over 20 years in senior management. In his most recent position as CEO of OpGen (2008-2009), Mr. Doheny led the transformation of an incubator lab services company into a systems company in less than two years. Prior to this, he held positions as Senior Vice President for the Molecular Diagnostics Division of Affymetrix Inc., Vice President of Pre-Analytical Solutions and a member of the Executive Committee at QIAGEN as well as President and CEO of BioStar Inc. (known as ThermoBioStar post-acquisition). Importantly for Epigenomics as it continues to build a US sales force, he has built several operating teams from the ground up, including the commercial teams to launch novel products at companies such as Ciba Corning, ThermoBiostar, and OpGen. Mr. Doheny obtained degrees in Biology and Chemistry from West Virginia University and attended Georgetown University for post-graduate studies in Biochemistry prior to moving into industry.

Other news from the department people

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics